2-(2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile, 95.0%, 5g

1,1,1,3,3,3-Hexamethyldisilazane>96.0%(GC)25mL

(2R,4S)-1-(tert-Butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid, 95.0%, 5g

6-Chloro-2-(chloromethyl)-3-fluoropyridine, 95%, 50mg

2-(3-(1H-Benzo[d]imidazol-1-yl)phenoxy)-9-(4-(tert-butyl)pyridin-2-yl)-9H-carbazole, 1g

5-Bromopyrimidine-2-carbohydrazide, 95%, 250mg

(5-Methylbenzofuran-2-yl)boronic acid, 95.0%, 1g

Ethyl 2-(Chloromethyl)acrylate (stabilized with HQ)>98.0%(GC)1g

(S)-1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid, 97.0%, 1g

2-Azaspiro[3.3]heptane, 95.0%, 250mg

(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol (R)-2-acetoxy-2-phenylacetate, 98%, 25g

3-OXO-3-(PYRIDIN-2-YL)PROPANENITRILE, 98.0%, 1g

Fmoc-HoCit-OH, 97%, 10g